 |
市场调查报告书
商品编码
1900313
干细胞製造市场规模、份额及成长分析（按产品、应用、最终用户及地区划分）－2026-2033年产业预测Stem Cell Manufacturing Market Size, Share, and Growth Analysis, By Product (Consumables (Culture Media, Other Consumables)), By Application (Research Applications), By End User, By Region - Industry Forecast 2026-2033 |
||||||
预计到 2024 年，干细胞製造市场规模将达到 150.5 亿美元，到 2025 年将达到 164.6 亿美元，到 2033 年将达到 337.8 亿美元，在预测期（2026-2033 年）内，复合年增长率为 9.4%。
干细胞生产市场预计将迎来强劲成长，这主要得益于生产和储存技术的进步，以及大众对干细胞衍生产品治疗益处的认识不断提高。多项研究表明，利用诱导多功能细胞（iPS细胞）、脂肪干细胞（ASCs）和胚胎干细胞（ESCs）等人类干细胞进行治疗，安全有效，可用于治疗包括器官修復和先天性缺陷重组在内的多种疾病。随着干细胞库生产和加工能力的提升，公私合作可望进一步扩大市场规模。在医疗环境不断变化的背景下，随着对干细胞库建设的深入研究和资金投入的增加，该行业有望实现显着增长。
干细胞製造市场驱动因素
人们对再生医学日益增长的兴趣是推动干细胞生产需求的主要因素。技术和方法的创新正在拓展干细胞的潜在应用，创造个人化治疗方案，并为慢性病管理提供解决方案。这种日益增长的兴趣不仅推动了临床和研究领域对干细胞产品和服务的需求，也刺激了对干细胞疗法研发投入的增加。因此，干细胞生产市场持续蓬勃发展，反映了这一充满前景的医学领域的显着进步。
干细胞製造市场限制因素
由于实验室研究和临床试验中干细胞的使用受到严格监管，干细胞製造业面临巨大的挑战。这些监管壁垒延长了新产品的研发和核准流程，为该领域的企业带来了不确定性。因此，企业可能被迫在这些限制条件下优先考虑创新，这可能导致投资减少和市场成长放缓。所以，儘管企业努力研发新的治疗方法，但由于需要应对复杂的监管环境，干细胞製造业的整体扩张可能会受到限制。
干细胞製造市场趋势
干细胞生产市场正经历一场变革性的趋势，其特点是融合了3D生物列印和CRISPR基因编辑等尖端技术。这种融合使得干细胞生产更加高效精准，提升了研发能力，并加速了治疗方法的开发。随着这些先进技术的不断发展，它们有望为创新治疗方法开闢新的途径，并激发业内人士对干细胞生产的兴趣和投资。这些技术的综效不仅革新了生产流程，也为再生医学的重大突破铺平了道路，最终促成了一个更充满活力和稳健的市场格局。
目录
介绍
- 调查目标
- 定义
- 市场覆盖范围
调查方法
- 资讯收集
- 二手和一手资讯来源
- 市场规模预测
- 市场假设与限制
执行摘要
- 前景
- 供需趋势分析
- 细分市场机会分析
市场动态与展望
- 市场动态
- 司机
- 机会
- 抑制因素
- 任务
- 波特分析
关键市场考察
- 关键成功因素
- 竞争程度
- 关键投资机会
- 市场生态系统
- 技术分析
- 供应链分析
- 价值链分析
- 定价分析
- 专利分析
- 客户和购买标准分析
干细胞製造市场：依产品分类
- 消耗品
- 培养基
- 其他消耗品
- 装置
- 生物反应器和培养箱
- 细胞分选装置
- 其他设备
- 干细胞株
- 造血干细胞
- 间质干细胞
- 诱导性多功能干细胞
- 胚胎干细胞
- 神经干细胞
- 多功能成体祖细胞
干细胞製造市场：依应用领域划分
- 研究用途
- 生命科学研究
- 药物发现与开发
- 临床应用
- 异体干细胞治疗
- 自体干细胞治疗
- 细胞和组织库应用
按最终用户分類的干细胞製造市场
- 製药和生物技术公司
- 学术、研究和受託研究机构
- 医院及手术中心
- 细胞和组织库
- 其他最终用户
干细胞製造市场：按地区分類的市场规模：
- 北美洲
- 美国
- 加拿大
- 欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
- 亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
- 拉丁美洲
- 巴西
- 其他拉丁美洲地区
- 中东和非洲（MEA）
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区
竞争格局
- 前五大公司对比
- 主要企业的市场定位（2025 年）
- 主要市场参与者所采取的策略
- 近期市集活动
- 主要企业市占率（2025 年）
主要企业简介
- Thermo Fisher Scientific, Inc.
- Merck KGaA
- Lonza Group
- Danaher Corporation
- Sartorius AG
- Becton, Dickinson and Company
- Eppendorf SE
- Corning Incorporated
- Bio-Rad Laboratories, Inc.
- Takara Bio Inc.
- Fujifilm Holdings Corporation
- Getinge AB
- Terumo Corporation
- Bio-Techne Corporation
- Himedia Laboratories Pvt. Ltd.
- Stemcell Technologies, Inc.
- Miltenyi Biotec GmbH
- Promocell
- Anterogen Co. Ltd.
- Cellgenix GmbH
- Pluristem Therapeutics Inc.
- Daiichi Sankyo
- Organogenesis Holdings Inc.
- Vericel Corp.
- American Cryostem Corp.
Stem Cell Manufacturing Market size was valued at USD 15.05 Billion in 2024 and is poised to grow from USD 16.46 Billion in 2025 to USD 33.78 Billion by 2033, growing at a CAGR of 9.4% during the forecast period (2026-2033).
The stem cell manufacturing market is poised for robust growth, fueled by advancements in manufacturing and storage technologies and increased public awareness of the therapeutic benefits of stem cell-derived products. Evidence from various studies highlights the safety and efficacy of stem cell therapy for treating a range of diseases, utilizing human stem cell types like induced pluripotent stem cells (iPSCs), adipose-derived stem cells (ASCs), and embryonic stem cells (ESCs) for organ repair and congenital defect reconstruction. Collaboration among public and private sectors is expected to enhance production and processing capabilities within stem cell banks, further driving market expansion. As research intensifies and funding for stem cell bank establishment increases, the segment anticipates significant growth amid an evolving healthcare landscape.
Top-down and bottom-up approaches were used to estimate and validate the size of the Stem Cell Manufacturing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Stem Cell Manufacturing Market Segments Analysis
Global Stem Cell Manufacturing Market is segmented by Product, Application, End User and Region. Based on Product, the market is segmented into Consumables (Culture Media, Other Consumables), Instruments (Bioreactors & Incubators, Cell Sorters, Other Instruments), Stem Cell Lines (Hematopoietic Stem Cells, Mesenchymal Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells, Neural Stem Cells, Multipotent Adult Progenitor Stem Cells). Based on Application, the market is segmented into Research Applications (Life Science Research, Drug Discovery & Development), Clinical Applications (Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy), Cell & Tissue Banking Applications. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Academic Institutes, Research Laboratories, and Contract Research Organizations, Hospitals & Surgical Centers, Cell & Tissue Banks, Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Stem Cell Manufacturing Market
The growing focus on regenerative medicine is a key factor propelling the demand for stem cell manufacturing. Innovations in technology and methodologies are expanding the potential applications of stem cells, enabling the creation of personalized treatments and offering solutions for chronic disease management. This surge in interest not only boosts the need for stem cell products and services within clinical and research environments but also encourages increased investment in the research and development of stem cell therapies. As a result, the marketplace for stem cell manufacturing continues to flourish, reflecting the significant advancements in this promising field of medicine.
Restraints in the Stem Cell Manufacturing Market
The stem cell manufacturing industry faces significant challenges due to stringent regulations that govern the use of stem cells in laboratory research and clinical trials. These regulatory hurdles can prolong the development and approval processes for new products, creating an environment of uncertainty for companies in the field. As a result, businesses may prioritize creativity and innovation within these constraints, which could lead to reduced investments and slower market growth. Consequently, the overall expansion of the stem cell manufacturing sector may be limited as companies navigate these complex regulatory landscapes while striving to bring new therapies to fruition.
Market Trends of the Stem Cell Manufacturing Market
The Stem Cell Manufacturing market is witnessing a transformative trend characterized by the integration of cutting-edge technologies such as 3D bioprinting and CRISPR gene editing. This convergence is facilitating more efficient and precise stem cell production, enhancing research capabilities and accelerating therapeutic developments. As these advanced technologies continue to evolve, they promise to unlock new avenues for innovative therapies, driving increased interest and investment within the sector. The synergy of these technologies is not only revolutionizing manufacturing processes but also paving the way for significant breakthroughs in regenerative medicine, ultimately contributing to a more dynamic and robust market landscape.
Table of Contents
Introduction
- Objectives of the Study
- Definitions
- Market Scope
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Executive Summary
- Market Overview Outlook
- Supply Demand Trend Analysis
- Segmental Opportunity Analysis
Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factor
- Degree of Competition
- Top Investment Pockets
- Ecosystem of the Market
- Technology Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Pricing Analysis
- Patent Analysis
- Customer & Buying Criteria Analysis
Stem Cell Manufacturing Market, By Product
- Market Overview
- Consumables
- Culture Media
- Other Consumables
- Instruments
- Bioreactors & Incubators
- Cell Sorters
- Other Instruments
- Stem Cell Lines
- Hematopoietic Stem Cells
- Mesenchymal Stem Cells
- Induced Pluripotent Stem Cells
- Embryonic Stem Cells
- Neural Stem Cells
- Multipotent Adult Progenitor Stem Cells
Stem Cell Manufacturing Market, By Application
- Market Overview
- Research Applications
- Life Science Research
- Drug Discovery & Development
- Clinical Applications
- Allogeneic Stem Cell Therapy
- Autologous Stem Cell Therapy
- Cell & Tissue Banking Applications
Stem Cell Manufacturing Market, By End User
- Market Overview
- Pharmaceutical & Biotechnology Companies
- Academic Institutes, Research Laboratories, And Contract Research Organizations
- Hospitals & Surgical Centers
- Cell & Tissue Banks
- Other End Users
Stem Cell Manufacturing Market Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Activities in the Market
- Key Companies Market Share (%), 2025
Key Company Profiles
- Thermo Fisher Scientific, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merck KGaA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Lonza Group
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Danaher Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sartorius AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Becton, Dickinson and Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Eppendorf SE
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Corning Incorporated
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bio-Rad Laboratories, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Takara Bio Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Fujifilm Holdings Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Getinge AB
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Terumo Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bio-Techne Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Himedia Laboratories Pvt. Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Stemcell Technologies, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Miltenyi Biotec GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Promocell
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Anterogen Co. Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cellgenix GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Pluristem Therapeutics Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Daiichi Sankyo
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Organogenesis Holdings Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Vericel Corp.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- American Cryostem Corp.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
